SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form N-CSR - Certified Shareholder Report:
SEC Accession No. 0001193125-24-042371
Filing Date
2024-02-22
Accepted
2024-02-22 10:55:30
Documents
4
Period of Report
2023-12-31
Effectiveness Date
2024-02-22

Document Format Files

Seq Description Document Type Size
1 HEALTH SCIENCES FUND_HSF_F114-050 d616036dncsr.htm N-CSR 3691176
2 302 CERTIFICATIONS d616036dex99cert.htm EX-99.CERT 20667
3 906 CERTIFICATIONS d616036dex99906ce.htm EX-99.906CE 4658
4 CODE OF ETHICS d616036dex99codeeth.htm EX-99.CODE ETH 26789
  Complete submission text file 0001193125-24-042371.txt   3745111

Series and Classes/Contracts Information:

Existing
  Status Name Ticker Symbol
CIK 0001002624      
Series S000002088   T. Rowe Price Health Sciences Fund, Inc.
Class/Contract C000005456   T. Rowe Price Health Sciences Fund, Inc. PRHSX
Class/Contract C000169937   T. Rowe Price Health Sciences Fund-I Class THISX
Mailing Address 100 EAST PRATT STREET BALTIMORE MD 21202
Business Address 100 EAST PRATT STREET BALTIMORE MD 21202 410-345-2000
T. Rowe Price Health Sciences Fund, Inc. (Filer) CIK: 0001002624 (see all company filings)

IRS No.: 521952906 | State of Incorp.: MD | Fiscal Year End: 1231
Type: N-CSR | Act: 40 | File No.: 811-07381 | Film No.: 24662981